H.R.2051: FAST Generics Act of 2017

About This Bill

Bill Version

Bill Summary

Fair Access for Safe and Timely Generics Act of 2017 or the FAST Generics Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation...

(Source: Library of Congress)

Bill Actions

Date Description
April 7, 2017
Referred to the Subcommittee on Health.
April 6, 2017
Referred to the House Committee on Energy and Commerce.
April 6, 2017

Introduced in the House by David McKinley (R-W.Va.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page